The largest database of trusted experimental protocols

Multiflo dispenser

Manufactured by Agilent Technologies
Sourced in United States

The MultiFlo dispenser is a liquid handling instrument designed for precise and automated dispensing of small volumes of liquids. It features multiple independent dispenser channels for simultaneously dispensing different reagents or samples into microplates or other labware. The MultiFlo dispenser is capable of accurately and consistently delivering volumes ranging from microliters to milliliters, making it a versatile tool for various laboratory applications.

Automatically generated - may contain errors

13 protocols using multiflo dispenser

1

Quantifying Luciferase Inhibition Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify the rate
of false positives reported during the PbLuc liver stage reconfirmation
screen, hits selected for tertiary round screening (405 compounds
from fresh DMSO stocks) were also tested for luminescent interference
between recombinant firefly luciferase and luciferin. Initially, 40
nL of selected compounds was dispensed using a Gen 4 Plus Acoustic
Transfer System (Biosero, San Diego, USA) at 1:3 in 12-point dose
response format (25 to 141.13 × 10–6 μM;
final DMSO concentration of 0.5% per well) in 1536-well, white, opaque-bottom
plates (ref# 789173-F, Greiner Bio-One). A 24-point single concentration
series of Luciferase Inhibitor-II (9.8 μM per well) was dispensed
as a positive control, while 96 wells of DMSO at 0.5% per well acted
as the negative control. Separately, a solution of 20 pM recombinant
luciferase (Promega cat# E170A) was prepared on ice by successive
dilutions (first 1:999 then into final solution at 20 pM) in phenol
naive DMEM (Invitrogen cat# 31053-028), 5% FBS (Corning), and 5×
Pen Strep Glutamine (Invitrogen). This solution was dispensed at 8
μL per well into the previously spotted plates using a MultiFlo
dispenser (BioTek) and incubated at room temperature for 1 h prior
to the addition of 1 μL of BrightGlo (Promega). Immediately
after the addition of BrightGlo, plates were read using the EnVision
Microplate reader (PerkinElmer).
+ Open protocol
+ Expand
2

High-Content Imaging of Malaria Gametocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to parasite addition,
10 nL (final concentration of 2 μM) of each compound was dispensed
using an Echo 550 acoustic dispenser (Labcyte) in 1536-well, black,
clear-bottom plates (ref# 789866-691-2B, Greiner Bio-One). High-content
imaging experiments were performed on stage V gametocytes as previously
described.51 (link) Briefly, mature gametocytes
were diluted to 0.5–0.75% gametocytemia and 1.25% hematocrit
in serum free screening media. Cultures were dispensed at 10 μL
per well using a MultiFlo dispenser (BioTek) and incubated at 37 °C
for 72 h (3% O2, 5% CO2, and 92% N2). A solution of 2.5 μM MitoTracker Red CMXRos and 0.13% saponin
(w/v) was made in screening media and added to each well for 1–2
h at 37 °C to allow for complete red blood cell lysis. The Operetta
(PerkinElmer) high content imaging platform was used to read all 1536-well
plates with the analysis performed by the accompanying Harmony software. Compounds with >50%
inhibition were resourced
from younger stocks and plated in 10-point dose response format. All
screening and analysis steps were then repeated as previously described.
+ Open protocol
+ Expand
3

Cytotoxicity Assay of Small Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rhabdomyosarcoma cell lines Rh30 and Rh6 were seeded in 384-well plates at 2500 cells per well, in 30 µL of media, using a BioTek MultiFlo dispenser. Cultures were grown overnight and then treated with drugs FGF401 (23029), PP1 (14244), Ruxolitinib (11609), and Stattic (14590) that were all purchased from Cayman Chemical. All of the pharmaceuticals were administered at the following concentrations using a D300e digital dispenser (Tecan Trading AG): 0.01, 0.0316, 0.1, 0.316, 1, 3.16, and 10 µM. After 72 h of drug treatment, cultures were treated with an equal volume of CellTiter-Glo reagent (Promega 2020-01-29). Luminescence was measured in a Biotek Instruments Inc. plate reader. The data was then analyzed using Prism GraphPad software.
+ Open protocol
+ Expand
4

Cryopreserved HEK-AC1 Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved HEK-AC1 cells were thawed, washed, resuspended in optiMEM and plated into white, flat bottom, tissue culture-treated 384 well plates (PerkinElmer) at 15 µl/well using a MultiFlo dispenser (BioTek). Cells were incubated in a 37°C humidified incubator for 1 h. Next, test compounds (3.5 mg/l final assay concentration) from the NDL-3000 Natural Derivatives library (TimTec) were added (70 nl/well) using a MultiPette-mounted 384 well pin tool and incubated at room temperature for 30 min. Following the incubation with test compounds, 5 µl/well of 3 µM A23187 in the presence of 30 nM forskolin and 500 µM IBMX (final concentrations) was added to the cells using a MultiFlo dispenser. Cells were incubated at room temperature for 1 h and cAMP accumulation was measured as described above using a MultiFlo dispenser to sequentially add 10 µl/well of cAMP-d2 and anti-cAMP cryptate conjugate working solutions (Cisbio Bioassays) to the cells. Average maximum cAMP values in the presence of the stimulants A23187 and forksolin were 187 ± 2.2 nM and minimum values (stimulants in the presence of W400) were 19.4 ± 0.3 nM during the screening campaign. Test compounds were screened in singlet and a Z’ factor of 0.55 ± 0.22 (n = 10) was obtained using 30 µM W400 as a positive control (15 (link), 16 (link)).
+ Open protocol
+ Expand
5

High-Throughput Cellular Assay Platform

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plate and liquid handling was performed using a HTS platform system composed of a Sciclone G3 Liquid Handler from PerkinElmer (Waltham, MA, USA), a MultiFlo™ Dispenser (Biotek Instruments, Bad Friedrichshall, Germany) and a Cytomat™ Incubator (Thermo Fisher Scientific, Waltham, MA, USA) (Schorpp and Hadian, 2014 (link)). Cell seeding and assays were performed in black 384-well CellCarrier-384 Ultra Microplates (PerkinElmer, 6057300). Image acquisition and image-based quantification was performed using an Operetta®/Columbus™ high-content imaging platform (PerkinElmer, USA).
+ Open protocol
+ Expand
6

High-throughput Cell Viability Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs diluted in dimethyl sulfoxide (DMSO) or water were dispensed at 30-nl volume to 384-well black plates (Corning, #3864) using an Echo 550 acoustic liquid handler (Labcyte). The compounds were plated at five different concentrations in threefold dilutions covering a concentration range relevant for each drug. Cell-killing benzethonium chloride (BzCl, 100 μM) and compound vehicle (DMSO, 0.1%) were used as positive and negative controls, respectively. Cells were diluted to medium at the desired concentration, and the suspension was dispensed to the predrugged plates at 30 μl using a MultiFlo dispenser (BioTek). After 7 days of incubation at 37°C, 10 μl of phosphate-buffered saline (PBS) containing Hoechst (4 μg/ml) and 1/10,000 CellTox Green Dye (Promega) was dispensed per well 1 hour before imaging at a Cytation5 image cytometer or an Opera Phenix (PerkinElmer) confocal screening microscope.
+ Open protocol
+ Expand
7

Isolation and Culture of Neonatal Rat Ventricular Myocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neonatal rat ventricular myocytes (NRVMs) were isolated from the hearts of 1–3 day-old Sprague Dawley rats (Charles River), as previously described [10 (link)]. Cell counting and viability was assayed using a Vi-Cell Cell Viability Analyzer (Beckman Coulter). Cells were dispensed using a 5 μL cassette in a MultiFlo dispenser (BioTek) onto 96-well clear-bottom plates (Greiner) coated with 0.2% gelatin (Sigma; G9391) in DMEM with 10% calf serum, 2 mM L-glutamine, and penicillin-streptomycin; each well received 10,000 cells in 100 mu;L of medium. The following morning, cells were washed with serum-free medium and maintained in DMEM supplemented with L-glutamine, penicillin-streptomycin and Neutridoma-SP (0.1%; Roche Applied Science). Cells were treated with PE (10 mu;M) or PMA (50 nM) for 48 h prior to fixation. Immediately after addition of hypertrophic agonist, compounds and controls were added to plates. A single column of negative control (DMSO, 8 wells) and a single column of positive control (Trichostatin-A (TSA), 200 nM, 8 wells) were included on all plates. Using a 96-tip MDT head on a Janus automated liquid handler (Perkin Elmer), 0.5 mu;L of each compound was delivered to each well at a final concentration of 10 mu;M (1 mu;M for the Kinase Inhibitor Library), yielding a residual DMSO concentration of 0.5%.
+ Open protocol
+ Expand
8

Tay-Sachs Fibroblast Calcium Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tay–Sachs fibroblasts were plated at 800 cells/well in 384-well black μClear plates (Greiner, cat. 781091) with a MultiFlo dispenser (BioTek, Winooski, VT) and cultured for 24 h at 37 °C, 5% CO2. Compounds were added to cells under sterile conditions and continued in culture for 72 h. On the day of assay, culture media was completely removed and replaced with 20 μL of dye loading buffer, 4.8 μM Fluo-8 AM (cat. 21083), and 1X Screen Quest Calcium Assay Buffer (cat. 36301) (both from AAT Bioquest, Sunnyvale, CA) in calcium-free HBSS containing 20 mM HEPES (pH 7.4) and incubated for 30 min at 37 °C, followed by room temperature for 30 min. Changes in fluorescence intensity are monitored on a Hamamatsu FDSS μCell fluorescence kinetic plate reader (excitation 480 nm, emission 540 nm) reading at 1 Hz for a 30 s baseline and followed by addition of 2-APB (25 μM final concentration). After 15 min, GPN (50 μM final concentration) was added and the change in fluorescence was continually recorded for an additional 10 min. The data from each well were normalized and expressed as a ratio by dividing the fluorescence over the entire real-time reading by the initial basal fluorescence recorded prior to GPN addition.
+ Open protocol
+ Expand
9

Comprehensive Glycan Profiling of RG-I

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified RG-I samples were dissolved in water and were coated onto ELISA plates [384 well clear flat bottom polystyrene high bind microplate (product no. 3700), Corning Life Sciences] on an equal weight (gravimetric) per well basis (0.5 μg/well). The samples were then subjected to ELISA screening with a comprehensive suite of cell wall glycan-directed monoclonal antibodies essentially as described earlier [40 (link), 61 (link)]. The ELISA screening assays were done using an Robotic System (Thermo Scientific) comprising an Orbitor RS Robotic Arm (Thermo Scientific) accessing the following components: Carousel plate storage/incubation (Thermo Scientific), EON Plate Reader (Biotek), EL406 ELISA Plate Washer (Biotek), Multiflo Dispenser (Biotek) and Precision XS Fluid Dispenser (Biotek). The whole system is operated by the laboratory automation software, Momentum 3.2.7 (Thermo Scientific). Water was used as the blanks and these background values were subtracted from the sample ELISA responses. The ELISA assays were done in technical duplicates and data represent the average of the replicates. Cell wall glycan-directed antibodies were were obtained from laboratory stocks (CCRC, JIM and MAC series) at the Complex Carbohydrate Research Center (available through CarboSource Services; http://www.carbosource.net) or through BioSupplies (Australia) (BG1, LAMP).
+ Open protocol
+ Expand
10

High-Throughput Cellular Assay Platform

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plate and liquid handling was performed using a HTS platform system composed of a Sciclone G3 Liquid Handler from PerkinElmer (Waltham, MA, USA), a MultiFlo™ Dispenser (Biotek Instruments, Bad Friedrichshall, Germany) and a Cytomat™ Incubator (Thermo Fisher Scientific, Waltham, MA, USA) (Schorpp and Hadian, 2014 (link)). Cell seeding and assays were performed in black 384-well CellCarrier-384 Ultra Microplates (PerkinElmer, 6057300). Image acquisition and image-based quantification was performed using an Operetta®/Columbus™ high-content imaging platform (PerkinElmer, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!